| Literature DB >> 18047595 |
Abstract
Mood disorders (MD) are a frequent comorbidity of epilepsy with a negative impact on quality of life. The higher prevalence of MD in people with epilepsy (PWE) is most likely a reflection of a bidirectional relation between the two conditions, and common pathogenic mechanisms. Treatment of MD in PWE is safe with selective serotonin reuptake inhibitor (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), but nonpsychiatrists need to know when to refer these patients to a psychiatrist for further evaluation and treatment.Entities:
Mesh:
Year: 2007 PMID: 18047595 DOI: 10.1111/j.1528-1167.2007.01395.x
Source DB: PubMed Journal: Epilepsia ISSN: 0013-9580 Impact factor: 5.864